chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt noted at a routine f/u for CKD/HD on 5/25 that they had itchy/dry skin/rash that developed after vaccination. No further info available regarding time course, location, or severity.  Most recent Moderna dose on 4/21.  Hx of CKD on HD, HTN, High Cholesterol, DM, Diabetic retinopathy, Vitreous hemorrhage.  Pt was taking ASA, atorvastatin, PhosLo, clopidogrel, docusate, furosemide, multivitamin at the time of vaccinations.
Headache, left arm is swollen at injection sight, shortness of breath, entire leg arm is hurting
sore arm for 2-3 days lump at injection site day 4 Covid arm = smaller lump but also 6-inch red ring around arm days 5-7 red itchy raised rash from day 8 on, beginning to spread down arm Now = itchier, redder, more raised, and almost to elbow
rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (rash).         No treatment information was provided.   Reporter did not allow further contact
Numbness in lips; Tingling sensation throughout body; Administration site: Left leg; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left leg on 19Mar2021 at 12:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure (BP). The patient had known allergies to amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced numbness in lips and tingling sensation throughout body. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with dental x-ray and PC visit to check for sign of ill. On an unknown date, the patient underwent dental x-ray and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness in lips and tingling sensation throughout body was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
This case was reported by a sales representative and described the occurrence of rash in an adult male subject who was vaccinated with FLUARIX. On 7 October 2008 the subject received a dose of FLUARIX at 0.5 ml. On 7 October 2008, and into the next day, the subject developed a generalized itchy rash. On 21 October 2008, the events of rash and itching were resolved. The healthcare professional considered these events unrelated to vaccination with FLUARIX. Similar events occurred in three additional subjects. Linked cases include: A0753760A, A0753770A, A0753771A. Follow-up information received on 07 November 2008 indicated that the events actually began on 08 October 2008. One day following vaccination with FLUARIX. The events resolved and were not considered to be related to treatment with FLUARIX.
Patient received first dose of Moderna on 3/18/21 and received second dose of vaccine on 4/1/2021 - being too soon to receive second dose of vaccine.
Severe muscle and joint pain throughout body making walking and doing daily activities extremely difficult or impossible that lasted for 36 hours approximately. Severe fatigue that made walking and doing daily activities extremely difficult or impossible that lasted for 36 hours approximately. Adverse event began at about 26 hours after receiving the Pfizer booster shot #1.
Rash starting on scalp & has spread to entire body; facial edema; joint pain.
This was my mom. She began to feel extreme fatigue and not herself the day after the vaccination. Almost immediately she was unable to walk. She went into an immediate and extreme physical decline.  Bed ridden. Hospice was called in on 1/30/2021, She passed away on 2/15/2021
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills Narrative:
Presented to ED w/ SOB; COVID +, admitted for COVID-19 pna w/ acute resp failure; tx w/O2 therapy, abx, steroids, thiamine, zinc; dc'd home on RA.
2 weeks after immunizations pt went to ER with temperature of 103 and small rash all over.
extensive hives on trunk, extremities, head, ears, eye area;denies any SOB or resp problems;onset eve of 5FEB97;notified PHN 8AM 6FEB97;advised MD;
informed per pt/mom that 8NOV95 pus & blood began oozing from inj site & swelling & pain + abscess 4x5cm w/3mm pustule;10NOV95 incision & drainage rt upper arm
arm-sore-took ATB-h/a, (severe & cont) rx Cephalexin
37 year old male arrived to observation area.  Pt. stated feeling nauseated, weakness.  Observed to be sweating.  Two episodes of emitus with clear fluid vomitus.  Denies any other pain.   Fire Rescue arrived at scene.  Vital signs rendered.  Pt. declined hospitalization at this time.  Patient recovered from adverse reaction.  PO fluids given as tolerated.  Pt denied any pain or discomfort.  Pt. left observation area at 12:05pm.
Information has been received from a registered nurse concerning a female who on 05/01/2000 was vaccinated with another physician's office with a dose of varicella vaccine. On 08/28/2001, the pt developed a herpetic eruption in linear clusters of clear fluid filed blisters on her right hsoulder'ls linear line. She also had four lesions on her chest. It was noted that the eruption appeared as shingles but had a non-dermatomal distrubution, thus the reporter felt that the experience was not shingles. It was reported that the pt recovered. Unspecified medical attention was sought. No further info is available.
1/2 hour after receiving injection had difficulty swallowing. When he did eat, it felt like food got "stuck" in in mid chest area. Had epigastric pain lasting a few minutes. Difficulty swallowing lasted 36 hours.
nausea; Throwing up; headache; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), NAUSEA (nausea), VOMITING (Throwing up) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033b21A and 025621a) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jun-2021, the patient experienced FATIGUE (tiredness). On 16-Jun-2021, the patient experienced NAUSEA (nausea), VOMITING (Throwing up) and HEADACHE (headache). At the time of the report, FATIGUE (tiredness), NAUSEA (nausea), VOMITING (Throwing up) and HEADACHE (headache) outcome was unknown.            No concomitant information was provided. No treatment medication was provided. Patient asked if it was alright to take an antacid.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up information received on 15 Jul 2021 contains non significant information.
Chills, overall body (bones; head to toe - every bone) ache, tired, fever, "clammy" skin the day after vaccine. May have started approx. midnight with chills (napped for 4 1/2 hrs, 10-2:30, woke up to fever broken).
Systemic: Nausea-Mild, Additional Details: PATIENT EXPERIENCED MILD NAUSEA IMMEDIATELY POST IMMUNIZATION. PARENT GAVE CHILD-PATIENT WATER. PARENT AND CHILD EXPRESSED IMPROVMENT PRIOR TO LEAVING PHARMACY. NO ONGOING CONCERNS.
she complained of a lot of pain in the arm; had given an M-M-R vaccine to a patient intramuscularly/She discovered that it was supposed to be given subcutaneousl; This spontaneous report as received from a pharmacist refers to a 58-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.      On 24-DEC-2020, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # S001329, expiration date: 14-JAN-2021, albumin status has been verified as recombinant human albumin (rHA), intramuscularly (exact dose and anatomical location were not reported) for booster. The patient researched that the vaccine was supposed to be given subcutaneously.   On that day, 30 minutes after receiving the vaccination, the patient complained of a lot of pain in the arm. She sought medical attention. The pharmacist recommended ice and ibuprofen to the patient but it was unknown if the patient did either of these treatments.  The outcome of the events was unknown. The relatedness between the events and suspect vaccine was not provided.
pt developed sharp chest pain to the right chest 6 minutes post vaccine denied radiation, 1341- 132/79 P-101 sat 99%, pain level 4/10, 1342- 119/86 Sat 98% P-99, 1345- 118/ 76 sat 98%  chest pain 0/10, 1348 -administered Benadryl, 25 mg by mouth per protocol, 1349-121/78 sat 98% P-95 chest pain 0/10, 1354- 120/82 sat 99% pain returned 3/10 called emergency medical services for transport, 1400-144/88 P-106 sat 95%, 1401- 129/84 sat 98% chest pain 0/10, 1402 emergency medical services arrived and took over care patient complained of intermittent chest pain with inspiration, pt signed medical waiver, then went to Urgent Care on her own with her clinical instructor (Nursing Student on Clinical Rotation)
3 patients received  a Dose administered >1224 hours post puncture; 3 patients received a second booster  and are not  immunocompromised or over 50 years of age; They state also that this vial did under went a temperature excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received  a Dose administered >12/24 hours post puncture), EXTRA DOSE ADMINISTERED (3 patients received a second booster  and are not  immunocompromised or over 50 years of age) and PRODUCT TEMPERATURE EXCURSION ISSUE (They state also that this vial did under went a temperature excursion) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056M21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: janssen (Patient received Janssen as primary series and booster dose.). Past adverse reactions to the above products included No adverse event with janssen.    On 03-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received  a Dose administered >12/24 hours post puncture), EXTRA DOSE ADMINISTERED (3 patients received a second booster  and are not  immunocompromised or over 50 years of age) and PRODUCT TEMPERATURE EXCURSION ISSUE (They state also that this vial did under went a temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 patients received  a Dose administered >12/24 hours post puncture), EXTRA DOSE ADMINISTERED (3 patients received a second booster  and are not  immunocompromised or over 50 years of age) and PRODUCT TEMPERATURE EXCURSION ISSUE (They state also that this vial did under went a temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had no Allergies  No concomitant medication information provided. No treatment medication information provided.
Information has been received from a registered nurse concerning a 14 year old male child who "within the last two weeks" on approximately 01-APR-2008 was vaccinated SQ with 0.5ml of VARIVAX (Merck) (lot # 660057/1806U). There was no concomitant medication. Subsequently, the patient developed a severe red raised area at the injection site after receiving the vaccination. Unspecified medical attention was sought. It was unspecified if lab studies were performed. At the time of the report, the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
Patient is a 77 yo male with a pmhx of DM, CAD who presents after syncopal episode. Per EMS, patient woke up this morning and felt dizzy. Went to restroom and after using bathroom, syncopized and hit his head on the bathtub. States his wife said he was unconscious for about 30-40 seconds. Patient does take plavix daily for previous TIA. No other blood thinners. Patient's wife thought he might be hypoglycemic and gave his BG, when EMS checked was in the 70s and they had him eat a sandwich. Patient takes glimepiride daily, no insulin. Did test positive for covid on Saturday and started Paxlovid yesterday. No headache, nausea, vomiting, CP, SOB. Still feeling dizziness when moving his head. Pt requesting to leave, does not want to be admitted. Dr. aware. Pt is leaving AMA
Prior to the vaccination, 03/12/2021 I had  increase frequency of urination. The doctor prescribed preventative antibiotics. There was a small trace of blood but not enough to warrant anything but to be preventative he wanted to prescribe the antibiotics. On 03/13/2021- the night  of the vaccine -I had cold sweats, &  fever.  After the vaccination, on 03/14/2021, late afternoon, I had lower back pain,  that escalated  until 03/20/2021.  The pain felt like I was going into labor. The pain did not subside. The pain stayed severe. On 03/20/201, I went to the urgent care, they gave me an injection of  Toradol 60 mg per 2ml and prescribed  cephalexin. After the urine culture came  she told me to stop taking the cephalexin, and prescribed yet another antibiotic. With the lab results the urologist said it should not be causing that level of pain.  The lower back pain, and the increase of urination subsided about a week prior to receiving the 2nd Dose, 04/10/2021.   The lower back pain and the increase of urination came back came back about 48 hours after the 2nd dose, but it was not any where near the level of pain as the 1st time after the 1st dose. The pain lasted about 2 weeks and subsided, but it never got to the intensity as the first time.  I am still being monitored by a urologist.
This spontaneous report was received from social media, refers to an unspecified group of young female patients (reported as young girls). The patient's medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with GARDASIL (dose, frequency, route of administration, expiry date and lot # were not specified) for prophylaxis. It was reported in the social media report that dangerous bills were being processed, not only to mandate this lethal injection but to allow minors to receive it without parental consent. This vaccine was presented under the guise of prophylactic treatment to prevent STDs. GARDASIL was given to millions of young girls in more than 52 countries around the world. On unknown dates, GARDASIL had caused unfathomable suffering, loss of life (death) and unspecified injuries in the unspecified number of girls. Cause of death was not reported. It was unknown if autopsy was performed. Outcome of the events unfathomable suffering and unspecified injuries were not reported. Causality of the events were not reported. This is one of the several reports.; Reported Cause(s) of Death: loss of life (death).
Patient was scheduled to receive the bivalent Moderna booster Covid vaccine but was provided with improper dose.  Received 0.25ml rather than 0.5ml. No adverse events reported.
This spontaneous report as received from a medical assistant refers to a 19 month old patient. On 19-NOV-2013 the patient was vaccinated with VARIVAX (Merck) (dose and route not reported) and PROQUAD (dose and route not reported) on the same day. No adverse effects were reported. It was unknown if the patient sought medical attention or not. At the time of report, the status of patient was unknown. Additional information has been requested.
Per patient himself, he describes the reactions happen about 1 to 1&1/2 hour after getting vaccinated. Rash appears on back, eyes dwell up with water & can't even open eyes, non-stop coughing & sneezing. Patient get exhausted & sleep straight for 12 hours. (no swelling of lips, tongue, or face & no difficulty breathing.
Initially  suffered a loss of taste about 4 hours after vaccination.  Taste was better by 7 pm (8.5 hours after injection).  After going to bed started to suffer chills and severe muscle aches.  Took Motrin for the pain.  Severe muscle aches and pain in sinuses continue at the time of submitting this report.  My wife suffered similar side effects to the first Shingles.  Additional Background information.  my wife and I both tested positive for Covid on Nov 2 2020.  We both took part in an phase 2 antibody trial.  Since this is a double blind trial, we don't know who received the antibodies, but my wife's condition did not improve where mine improved almost immediately after the infusion
Significant Fatigue; headache; runny nose; slower cognition. Aches and pains,
Nausea, vomiting, light headedness, pale skin. Felt like he was going to black-out.
blood sugar went higher; tiredness; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NOVOLOG. The following information was reported: BLOOD GLUCOSE INCREASED (non-serious), outcome "unknown", described as "blood sugar went higher"; FATIGUE (non-serious), outcome "unknown", described as "tiredness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Client father contacted this office per phone 1/8/07 and stated his son who seen in ER over the week end an area on left arm swollen and reddened. Stated son itched and scratched area and doctor at ER told him to find out which vaccine as may had allergic reaction. Asked Client to bring child to office to observation as 2 vaccine given on left arm. MMR and DTaP. Client did not return with child 1/8, 1/9 or 1/10/07.
left ear partially and suddenly lost hearing, woke up in the morning and found can't hear many things and feels like the left ear is blocked and covered by something, and the second day is getting worse. visit doctor on the second day and doctor prescribed prednisone, this is the third day, still the same, can't hear many things
Patient received IPV, DTAP, HIB and Prevnar on 1/29/03. Patient had fever of 103 after shots, decreased appetite, crying for two nights. Patient seen 1/31/03 with fever 101.5, head shaking episodes X 3 and URI. Patient will follow up.
Pt. contacted clinic on 05/06/08stating that at 0600 on 05/02/08 (day after Tdap) he experienced chiils, fever of 101, dizziness, headache, & feeling as if his throat was constricting.  There was no local reaction noted by pt. & he did not seek medical treatment at the time.  He reported feeling fine by the next day.***Pt. regularly receives allergy shots which were administerd in each arm at that appt.
Miscalculated the patient's age as 11.  When trying to bill administration fee later in the evening, realized we gave the 5 - 11yo dose instead of the 12+ dose.
Narrative: Pt received his 1st COVID vaccine on 4/16/2021 and a coupe of day later, pt noted significant chest pain. During this time pt has also been doing a lot of push-ups that exacerbated the pain. Pt presented to the ED w/ c/o of chest pain, denied any SOB or radiating pain. Worked up at the ED included imaging, EKG, trops, and any potential dx was ruled out. Pt received toradol and experienced resolution of symptoms. Pt received 2nd dose of COVID vaccine and has not reported any side effects.
On 4/30/2021 I recieved the Covid-19 vaccine and on 5/1/2021 I started with upper abdominal pain and nauesa. It went away and came back on 5/3/2021, went away and came back on 5/5/2021 with the pain and nausea intensifying. I went to ER on 5/6/2021 at 1 am. When I arrived to the ER they proceeded to do bloodwork, also ordered an x-ray to ensure that my lungs were not causing an issue due to where pain was located. After the labs came back they saw my liver numbers were extremely high, so then they ordered a CT scan with contrast. CT scan showed everything to be normal. They then determined I needed to be admitted due to believing I had a stone in my bile duct, Gallbladder was removed in 2019. The MRI was done at 7pm on 5/6/2021. The results were recieved on 5/7/2021 and showed my bile duct was clear of obstructions. They continued to monitor my liver numbers and I was released today 5/9/2021 due to my numbers continually decreasing with instructions to follow-up with my PCP to have labs run again to ensure my numbers remained on decline to the normal range. I was also instructed to do the adverse event reports as to them not having enough data to determine if the vaccine may have been the reason for my high numbers. My PCP had just had my yearly labs done on 3/16/2021 and my liver numbers were normal.
Wheezing, chest tight, burning/red watery eyes, shortness of breath started 30-45 minutes after vaccine.
4 cm circular rash with centered pustule and itching on right arm surrounding MPX injection site.
Awoke morning of June 28th with sudden and sever pain in left shoulder progressing into back and neck then spreading down arm and hand causing sever pain, spasms in neck, back, shoulder, elbow, arm and hand along with numbness in little and ring finger of left hand. Limited sleep due to extreme pain for 2 - 3 weeks using 600 mg ibuprofen. Pain, spasms numbness persisted and lessening over about 6 more weeks. I still have limited mobility in left shoulder without pain and random spasms in left arm and numbness. I have extensively researched and the auto-immune response of Parsonage-Turner syndrome with brachial neuritis from this vaccine seems to be exactly what I have experienced.
Initially I reported an arm ash running down my left arm but after 30 days from injection #2 I now have a rash all over my body from head to toe as stated by my personal physician.  I take Benadryl for the itch infrequently.
Day 2 after vaccine: hives on hips, stomach, armpits and buttocks (noticed upon waking @5am).   Day 3 after vaccine: hives on hips and stomach, and a few on buttocks.   Claritin helped.
Pt recvd vax & 24 to 36 hrs p/vax devel pruritic papular rash; pt treated w/antihistamines & 4 to 5 days later rash remitted No further details were provided